Xtl Biopharmaceuticals XTLB Revenue Breakdown

NASDAQ XTLB
$2.40 +0.19 (+8.60%)
At close: Sep 30, 2026 · 4:00 PM EDT
No revenue breakdown for XTLB Xtl Biopharmaceuticals does not report revenue split by segment, product or geography.